Dissertation > Excellent graduate degree dissertation topics show

Detection and Quantification of Th17 Cells and IL-17 in the Peripheral Blood and Tumor Tissue in Patients with Non-small Cell Lung Cancer

Author: XuXiuJuan
Tutor: TaoMin
School: Suzhou University
Course: Oncology
Keywords: Th17 cell IL-17 NSCLC
CLC: R734.2
Type: Master's thesis
Year: 2011
Downloads: 65
Quote: 0
Read: Download Dissertation

Abstract


【Objective】To investigate Th17 cell quantification and the concentrations of cytokine IL-17 in patients with non-small cell lung cancer(NSCLC), and to explore the possible pathological mechanism of these cells involved in the development of NSCLC.【Methods】Eighty-three patients with newly diagnosed non-small cell lung cancer (NSCLC) were involved in the study from July 2010 to January 2011, and 20 healthy volunteers were recruited as normal controls (NCs). Th1 and Th17 cells in blood samples from NSCLC patients were evaluated with flow cytometry (FCM), and the concentrations of cytokine IL-17 in serum were measured by enzyme-linked immunosorbent assay (ELISA). Immunohistochemistry(IHC) was used to determine IL-17 expression in paraffin-embedded tissues with NSCLC, and the mRNA expression levels of IL-17 in tumor tissues were investigated by real-time fluorescence quantitative PCR (real-time PCR). The potential interrelationship of Th17 cells, IL-17~+cells or IL-17 and the clinical parameters of NSCLC patients were analyzed.【Results】1. Compared with normal controls, patients with NSCLC showed lower quantification of Th1 cells (5.09±2.52% vs 6.83±2.02%, P<0.05) and higher quantification of Th17 cells and IL-17 concentrations(1.59±0.97% vs 0.69±0.41%, P<0.05), (8.13±4.89 pg/ml vs 4.92±2.20 pg/ml, P<0.05).2. The quantification of Th17 cells and IL-17 concentrations had postive correlation with the clinical stage, patients with advanced disease(stageⅢ-Ⅳ) were higher than early disease(stageⅠ-Ⅱ) (1.73±1.04% vs 1.22±0.79%, P<0.05), (8.13±4.89pg/ml vs 5.30±3.33pg/ml, P=0.054). For further analysis, IL-17 concentrations were significantly higher in patients with advanced disease (stageⅢ-Ⅳ) than those in normal controls(8.13±4.89 pg/ml vs 4.92±2.20 pg/ml, P<0.05).3. Th17 cell quantification in NSCLC patients show positive correlation with IL-17 concentrations(r=0.20, P=0.22), but the difference was not statistically significant.4. Compared with peritumor tissues, intratumor tissues showed higher expression of IL-17~+cells and IL-17mRNA((16/35)% vs (0/10)%, P<0.01), (0.0284±0.0066 vs 0.0029±0.0009, P <0.01).5. The expression of IL-17~+ cells in intratumor tissues had postive correlation with the clinical stage and mediastinal lymph node, patients with advanced disease (stageⅢ) were higher than those in early disease(stageⅠ-Ⅱ)((9/13)% vs (7/22)%, P<0.05), and patients with positive mediastinal lymph node(N2) were higher than those with negative(N0-1) ((8/10)% vs (8/25)%, P<0.05). The expression of IL-17mRNA in patients with advanced disease (stageⅢ)were higher than those in early disease(stageⅠ-Ⅱ) (0.0399±0.0121 vs 0.0191±0.0058, P=0.087)6. The IL-17~+ cells per HPF in intratumor tissues show positive correlation with the levels of IL-17mRNA (r=0.64, P<0.01).【Conclusion】There are higher quantification of Th17 cells and higher expression of IL-17 in the peripheral blood and intratumor tissue in patients with NSCLC and they have postive correlation with the clinical stage. Detecting the quantification of Th17 cells and expression of IL-17 would contribute to prediction of the disease progression and prognosis.

Related Dissertations

  1. Effects of Blockade of IL-17 in Already Established Asthma of BALB/c Mice,R562.25
  2. A Stuty on the Diversification of Interleukin-17 of Asthma Mouse and the Affection of the Treament of Glucocorticoids,R562.25
  3. Effect of Transfection of TFPI-2 Plasmid on Lung Cancer NCI-H460 Cells,R734.2
  4. Clinical Study of Endostar Combined with Pemetrexed for Advanced Non-small Cell Lung Cancer,R734.2
  5. Association of Expression of ERCC1/RRM1 with Survival and Resistance to Platinum Inpatients with Ⅰ-ⅢA NSCLC,R734.2
  6. Asthma serum IL-17 and IgE changes and Correlation Analysis,R562.25
  7. Expression and Pathobiological Significance of Survivin, p53 and Bcl-2 Proteins in NSCLC,R734.2
  8. A Haplotype of TGFBR1 is Predominantly Found in Non-small-cell Lung Cancer Patients Displaying TGFBR1 Allelic-specific Expression,R734.2
  9. Establish the Detection Methods of miRNA in Tissue/Serum of NSCLC by Real-time Fluorescence Quantitative PCR and xMAP Bead-based Suspension Array and Their Application Research,R734.2
  10. The Assay and Clinical Significance of TC17 Cells and Its Main Effect Cytokine IL-17 in the Peripheral Blood of NSCLC Patients,R734.2
  11. The Primary Study of Biomarkers for the Early Detection and the Treatment Effects Prediction of Human NSCLC,R734.2
  12. Association of Decorin Proximal Promoter and 5’-UTR Methylation Status with Non-small Cell Lung Cancer,R734.2
  13. The Correlation Analysis of Currative Effect between the Tumor Markers and the Treatment of Gefitinib in Advanced NSCLC Patients,R734.2
  14. Studies on the Expression of Bmi-1 and C-myc in Non-small Cell Lung Cancer and Their Correlation,R734.2
  15. Function of Th17 Cells and Change of CD4~+CD25~+T Regulatory Cells in Children with Henoch-Schonlein Purpura in Acute,R725.5
  16. Preliminary Study on the Relationship between Non-small Cell Lung Epithelial Mesenchymal Transition and Metastasis and Its Influencing Factors,R734.2
  17. Hypoxia Induced Pemetrexed Resistance in Human Non-small Cell Lung Cancer Via Hypoxia-inducible Factor 1α,R734.2
  18. Study on the Expression Level of Toll-like Receptor-4 and Interleukin-17 in a Mouse Model of Systemic Candidiasis,R519
  19. The Dynamic Expression of Induced IL-17 and IL-23 from Mice Infected with Schistosoma Japonicum,R392
  20. The Relationship between Expression of Interleukin-17 and Ventricular Arrhythmia in Rats with Chronic Heart Failure,R541.7
  21. Research on Effection and Mechanism of Radiosensitivity of Non-small Cell Lung Cancer Cell Line H358 Following Gefitinib Treatment,R734.2

CLC: > Medicine, health > Oncology > Respiratory system tumors > Lung tumors
© 2012 www.DissertationTopic.Net  Mobile